{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T18:23:52Z","timestamp":1789237432741,"version":"build-2803163510"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:00:00Z","timestamp":1770508800000},"content-version":"am","delay-in-days":344,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001168","name":"Cancer Council Queensland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001168","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001793","name":"Queensland University of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ejphar.2025.177300","type":"journal-article","created":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T10:51:53Z","timestamp":1737802313000},"page":"177300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Lactoferrin conjugated radicicol nanoparticles enhanced drug delivery and cytotoxicity in prostate cancer cells"],"prefix":"10.1016","volume":"991","author":[{"given":"Zeinab","family":"Kooshan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srilakshmi","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taskeen Iqbal","family":"Janjua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirali","family":"Popat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4646-6247","authenticated-orcid":false,"given":"Jyotsna","family":"Batra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.177300_bib1","doi-asserted-by":"crossref","DOI":"10.1021\/acsami.9b10164","article-title":"Dual-targeted lactoferrin shell-oily core nanocapsules for synergistic targeted\/herbal therapy of hepatocellular carcinoma","author":"Abdelmoneem","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejphar.2025.177300_bib2","article-title":"Emerging frontiers in nanomedicine targeted therapy for prostate cancer","volume":"37","author":"Adekiya","year":"2023","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.ejphar.2025.177300_bib3","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1080\/10717544.2018.1440666","article-title":"Regression of prostate tumors after intravenous administration of lactoferrin-bearing polypropylenimine dendriplexes encoding TNF-alpha, TRAIL, and interleukin-12","volume":"25","author":"Altwaijry","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejphar.2025.177300_bib4","article-title":"Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy","volume":"1876","author":"Anwar","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.ejphar.2025.177300_bib5","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1021\/acsbiomaterials.0c01354","article-title":"Protein nanoparticles for enhanced oral delivery of coenzyme-Q10: in vitro and in silico studies","volume":"9","author":"Banun","year":"2023","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.ejphar.2025.177300_bib6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","article-title":"2022 update on prostate cancer epidemiology and risk factors-A systematic review","volume":"84","author":"Bergengren","year":"2023","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejphar.2025.177300_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100962","article-title":"Current therapy and drug resistance in metastatic castration-resistant prostate cancer","volume":"68","author":"Cai","year":"2023","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.ejphar.2025.177300_bib9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ccell.2016.07.004","article-title":"Mitochondrial akt regulation of hypoxic tumor reprogramming","volume":"30","author":"Chae","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejphar.2025.177300_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413435","article-title":"Targeting mitochondrial OXPHOS and their regulatory signals in prostate cancers","volume":"22","author":"Chen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177300_bib12","doi-asserted-by":"crossref","first-page":"8461","DOI":"10.1021\/acs.jmedchem.9b00565","article-title":"Identification of novel resorcinol amide derivatives as potent and specific pyruvate dehydrogenase kinase (PDHK) inhibitors","volume":"62","author":"Cho","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2025.177300_bib14","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s11864-023-01121-z","article-title":"Genomic and phenotypic biomarkers for precision medicine guidance in advanced prostate cancer","volume":"24","author":"Davoudi","year":"2023","journal-title":"Curr Treat Option On"},{"key":"10.1016\/j.ejphar.2025.177300_bib15","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1186\/s12885-015-1884-7","article-title":"Network analysis of an in vitro model of androgen-resistance in prostate cancer","volume":"15","author":"Detchokul","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejphar.2025.177300_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-36492-8","article-title":"Anticancer activity of lactoferrin-coated biosynthesized selenium nanoparticles for combating different human cancer cells via mediating apoptotic effects","volume":"13","author":"El-Fakharany","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.177300_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116008","article-title":"Targeting the pyruvate dehydrogenase complex\/pyruvate dehydrogenase kinase (PDC\/PDK) axis to discover potent PDK inhibitors through structure-based virtual screening and pharmacological evaluation","volume":"264","author":"Gan","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2025.177300_bib21","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.2741\/212","article-title":"Lactoferrin and cancer in different cancer models","volume":"3","author":"Gibbons","year":"2011","journal-title":"Front Biosci (Schol Ed)"},{"key":"10.1016\/j.ejphar.2025.177300_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2008.07.020","article-title":"Lactoferrin: structure, function and applications","volume":"33","author":"Gonzalez-Chavez","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejphar.2025.177300_bib23","article-title":"Role of lactoferrin in the carcinogenesis of triple-negative breast cancer","volume":"1","author":"Gopal","year":"2016","journal-title":"J Cancer Clin Trials"},{"key":"10.1016\/j.ejphar.2025.177300_bib24","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3389\/fonc.2018.00200","article-title":"Bovine milk lactoferrin selectively kills highly metastatic prostate cancer PC-3 and osteosarcoma MG-63 cells in vitro","volume":"8","author":"Guedes","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejphar.2025.177300_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2023.113830","article-title":"Combined inhibition of pyruvate dehydrogenase kinase 1 and hexokinase 2 induces apoptsis in non-small cell lung cancer cell models","volume":"433","author":"Guo","year":"2023","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejphar.2025.177300_bib26","first-page":"213","volume":"vol. 6","author":"Hajiyeva","year":"2021"},{"key":"10.1016\/j.ejphar.2025.177300_bib27","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2025.177300_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18081620","article-title":"Melatonin decreases glucose metabolism in prostate cancer cells: a (13)C stable isotope-resolved metabolomic study","volume":"18","author":"Hevia","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177300_bib31","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.molcel.2011.10.015","article-title":"Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism","volume":"44","author":"Hitosugi","year":"2011","journal-title":"Mol Cell"},{"key":"10.1016\/j.ejphar.2025.177300_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtbi.2023.111434","article-title":"A reduced model of cell metabolism to revisit the glycolysis-OXPHOS relationship in the deregulated tumor microenvironment","volume":"562","author":"Jacquet","year":"2023","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.ejphar.2025.177300_bib35","doi-asserted-by":"crossref","first-page":"16909","DOI":"10.1039\/D1NR03553C","article-title":"Facile synthesis of lactoferrin conjugated ultra small large pore silica nanoparticles for the treatment of glioblastoma","volume":"13","author":"Janjua","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.ejphar.2025.177300_bib36","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jconrel.2023.03.040","article-title":"Efficient delivery of Temozolomide using ultrasmall large-pore silica nanoparticles for glioblastoma","volume":"357","author":"Janjua","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.ejphar.2025.177300_bib38","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.colsurfb.2018.05.008","article-title":"Hyaluronate\/lactoferrin layer-by-layer-coated lipid nanocarriers for targeted co-delivery of rapamycin and berberine to lung carcinoma","volume":"169","author":"Kabary","year":"2018","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejphar.2025.177300_bib39","doi-asserted-by":"crossref","first-page":"9703","DOI":"10.3390\/molecules20069703","article-title":"Multifunctional iron bound lactoferrin and nanomedicinal approaches to enhance its bioactive functions","volume":"20","author":"Kanwar","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2025.177300_bib40","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.str.2007.07.001","article-title":"Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol","volume":"15","author":"Kato","year":"2007","journal-title":"Structure"},{"key":"10.1016\/j.ejphar.2025.177300_bib41","first-page":"5","article-title":"A comprehensive review of advanced nano-biomaterials in regenerative medicine and drug delivery","volume":"8","author":"Khalilov","year":"2023","journal-title":"Advances in Biology & Earth Sciences"},{"key":"10.1016\/j.ejphar.2025.177300_bib44","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.2217\/nnm-2020-0090","article-title":"Targeting cancer with lactoferrin nanoparticles: recent advances","volume":"15","author":"Kondapi","year":"2020","journal-title":"Nanomedicine (London, England)"},{"key":"10.1016\/j.ejphar.2025.177300_bib48","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1073\/pnas.1102808108","article-title":"Probing the invasiveness of prostate cancer cells in a 3D microfabricated landscape","volume":"108","author":"Liu","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejphar.2025.177300_bib50","first-page":"372","article-title":"Antibody-mediated targeting of the transferrin receptor in cancer cells","volume":"73","author":"Luria-Perez","year":"2016","journal-title":"Bol. Med. Hosp. Infant. Mex."},{"key":"10.1016\/j.ejphar.2025.177300_bib54","doi-asserted-by":"crossref","first-page":"9307","DOI":"10.1007\/s11033-023-08828-0","article-title":"The synergistic effects of betanin and radiotherapy in a prostate cancer cell line: an in vitro study","volume":"50","author":"Montazersaheb","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ejphar.2025.177300_bib57","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1158\/1078-0432.CCR-11-1000","article-title":"Hsp90 molecular chaperone inhibitors: are we there yet?","volume":"18","author":"Neckers","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2025.177300_bib59","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1038\/s41388-018-0582-8","article-title":"The ERK and JNK pathways in the regulation of metabolic reprogramming","volume":"38","author":"Papa","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2025.177300_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1275749","article-title":"A novel small molecule, CU05-1189, targeting the pleckstrin homology domain of PDK1 suppresses VEGF-mediated angiogenesis and tumor growth by blocking the Akt signaling pathway","volume":"14","author":"Park","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177300_bib62","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/path.4547","article-title":"A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy","volume":"236","author":"Pertega-Gomes","year":"2015","journal-title":"J. Pathol."},{"key":"10.1016\/j.ejphar.2025.177300_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136968","article-title":"Investigating the common pharmacophoric points of PDK1 inhibitors as anti-cancer agents using an alignment independent 3D-QSAR, molecular docking and molecular dynamic simulation","volume":"1300","author":"Piri","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejphar.2025.177300_bib66","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.canlet.2021.08.033","article-title":"Chemotherapy in metastatic castration-resistant prostate cancer: current scenario and future perspectives","volume":"523","author":"Ruiz de Porras","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2025.177300_bib67","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1158\/1078-0432.CCR-17-1957","article-title":"Hyperpolarized [1-(13)C]-Pyruvate magnetic resonance spectroscopic imaging of prostate cancer in vivo predicts efficacy of targeting the Warburg effect","volume":"24","author":"Scroggins","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2025.177300_bib68","doi-asserted-by":"crossref","DOI":"10.1038\/srep32062","article-title":"Doxorubicin conjugated to immunomodulatory anticancer lactoferrin displays improved cytotoxicity overcoming prostate cancer chemo resistance and inhibits tumour development in TRAMP mice","volume":"6","author":"Shankaranarayanan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.177300_bib69","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/cpr.12192","article-title":"Independent effect of polymeric nanoparticle zeta potential\/surface charge, ontheir cytotoxicity and affinity to cells","volume":"48","author":"Shao","year":"2015","journal-title":"Cell Proliferat"},{"key":"10.1016\/j.ejphar.2025.177300_bib70","first-page":"916","article-title":"Transferrin receptor 1 in cancer: a new sight for cancer therapy","volume":"8","author":"Shen","year":"2018","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.ejphar.2025.177300_bib71","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejphar.2025.177300_bib72","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.1158\/0008-5472.CAN-19-4036","article-title":"Nanoengineered disruption of heat shock protein 90 targets drug-induced resistance and relieves natural killer cell suppression in breast cancer","volume":"80","author":"Smalley","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2025.177300_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067025","article-title":"Numerical modeling of interstitial fluid flow coupled with blood flow through a remodeled solid tumor microvascular network","volume":"8","author":"Soltani","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2025.177300_bib74","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1080\/10717544.2018.1440666","article-title":"Regression of prostate tumors after intravenous administration of lactoferrin-bearing polypropylenimine dendriplexes encoding TNF-\u03b1, TRAIL, and interleukin-12 AU - altwaijry, Najla","volume":"25","author":"Somani","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejphar.2025.177300_bib75","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jconrel.2015.09.003","article-title":"Enhanced gene expression in the brain following intravenous administration of lactoferrin-bearing polypropylenimine dendriplex","volume":"217","author":"Somani","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.ejphar.2025.177300_bib77","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1158\/2159-8290.CD-14-1057","article-title":"A large-scale analysis of genetic variants within putative miRNA binding sites in prostate cancer","volume":"5","author":"Stegeman","year":"2015","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejphar.2025.177300_bib79","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1021\/mp500238m","article-title":"Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas","volume":"11","author":"Su","year":"2014","journal-title":"Mol Pharmaceut"},{"key":"10.1016\/j.ejphar.2025.177300_bib80","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1373\/clinchem.2018.299651","article-title":"Emergence of MicroRNAs as key players in cancer cell metabolism","volume":"65","author":"Subramaniam","year":"2019","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ejphar.2025.177300_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13143582","article-title":"Allele-specific MicroRNA-mediated regulation of a glycolysis gatekeeper PDK1 in cancer metabolism","volume":"13","author":"Subramaniam","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejphar.2025.177300_bib85","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1007\/s00018-005-5371-1","article-title":"Mammalian lactoferrin receptors: structure and function","volume":"62","author":"Suzuki","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejphar.2025.177300_bib90","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.etap.2018.08.002","article-title":"MicroRNA-375 inhibits the proliferation, migration and invasion of kidney cancer cells by triggering apoptosis and modulation of PDK1 expression","volume":"62","author":"Wang","year":"2018","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177300_bib93","doi-asserted-by":"crossref","first-page":"228","DOI":"10.20892\/j.issn.2095-3941.2017.0052","article-title":"Recent progress on nanoparticle-based drug delivery systems for cancer therapy","volume":"14","author":"Xin","year":"2017","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.ejphar.2025.177300_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101466","article-title":"Reprogramming hormone-sensitive prostate cancer to a lethal neuroendocrine cancer lineage by mitochondrial pyruvate carrier (MPC)","volume":"59","author":"Xu","year":"2022","journal-title":"Mol Metab"},{"key":"10.1016\/j.ejphar.2025.177300_bib96","article-title":"Biosynthesis, characterization, and investigation of antimicrobial and cytotoxic activities of silver nanoparticles using Solanum tuberosum peel aqueous extract","volume":"9","author":"Xu","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.ejphar.2025.177300_bib100","article-title":"Phase of care prevalence for prostate cancer in New South Wales, Australia: a population-based modelling study","volume":"12","author":"Yu","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2025.177300_bib102","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.18632\/aging.204115","article-title":"Identification of biomarkers for immunotherapy response in prostate cancer and potential drugs to alleviate immunosuppression","volume":"14","author":"Zhang","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.ejphar.2025.177300_bib107","doi-asserted-by":"crossref","DOI":"10.1007\/s12094-019-02055-5","article-title":"Expression of PDK1 in malignant pheochromocytoma as a new promising potential therapeutic target","author":"Zhang","year":"2019","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.ejphar.2025.177300_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216425","article-title":"Combined inhibition of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase a induces metabolic and signaling reprogramming and enhances lung adenocarcinoma cell killing","author":"Zhou","year":"2023","journal-title":"Cancer Lett."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925000536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925000536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:27:29Z","timestamp":1762144049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925000536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":62,"alternative-id":["S0014299925000536"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177300","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lactoferrin conjugated radicicol nanoparticles enhanced drug delivery and cytotoxicity in prostate cancer cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177300","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"177300"}}